An interim FTC report outlined how the rise of vertical integration and concentration has led to devastating results for both patients and fragile pieces of the health care delivery system.
Mary Caffrey
Advertisement
Articles by Mary Caffrey
Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."
Researchers shared findings from the ACCESS study presented at the 72nd American College of Cardiology Annual Scientific Sessions.
Advertisement
Latest Updated Articles
Does the Cost of Preventive Drugs Change Health Outcomes?Published: March 6th 2023 | Updated:
In July, PBMs Found Themselves in the Federal Government Hot SeatPublished: August 5th 2024 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
2
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
3
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
4
